Promoter DNA melting, culminating in the loading of the single-stranded DNA template into the RNA polymerase active site, is a key step in transcription initiation. Recently, the first transcription inhibitors found to block distinct steps of promoter melting were characterized. Here, the impact of these studies is discussed with respect to the current models of transcription initiation.Bacterial RNA polymerase (RNAP) is a complex molecular machine, composed of the catalytic core (subunits 2abb'v) and one of the promoter-specific s factors directing promoter recognition and melting. Transcription initiation, governed by the interplay between a panoply of promoter sequences and a number of s factors, is modulated by numerous transcriptional activators, repressors and small regulatory molecules. Such a network provides the basis for the fine-tuning of bacterial gene expression. Understanding transcriptional regulation requires the characterization of the intermediates and checkpoints in the initiation pathway leading to a transcriptionally active RNAP-promoter complex, generically referred to as RP o . The antibiotics lipiarmycin (Lpm) and myxopyronin (Myx), which target two distinct steps in forming RP o ,1-3 open up new perspectives for fundamental studies of transcriptional regulation and for medical research to identify new drug target sites.